Li, J. (2018). Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage. American Society of Hematology (ASH).
Chicago Style (17th ed.) CitationLi, J. Mutant Calreticulin Knockin Mice Develop Thrombocytosis and Myelofibrosis Without a Stem Cell Self-renewal Advantage. American Society of Hematology (ASH), 2018.
MLA (9th ed.) CitationLi, J. Mutant Calreticulin Knockin Mice Develop Thrombocytosis and Myelofibrosis Without a Stem Cell Self-renewal Advantage. American Society of Hematology (ASH), 2018.
Warning: These citations may not always be 100% accurate.